[et_pb_section bb_built=”1″ admin_label=”Header – All Pages” transparent_background=”off” background_color=”#1e73be” allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off” custom_padding=”0px||0px|” next_background_color=”#000000″ custom_padding_tablet=”50px|0|50px|0″ custom_padding_last_edited=”on|desktop” global_module=”1221″][et_pb_row admin_label=”row” global_parent=”1221″ make_fullwidth=”off” use_custom_width=”off” width_unit=”on” use_custom_gutter=”off” custom_padding=”||5px|” allow_player_pause=”off” parallax=”off” parallax_method=”on” make_equal=”off” parallax_1=”off” parallax_method_1=”off” background_position=”top_left” background_repeat=”repeat” background_size=”initial”][et_pb_column type=”4_4″][et_pb_post_title global_parent=”1221″ title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”off” featured_placement=”below” parallax_effect=”on” parallax_method=”on” text_orientation=”left” text_color=”light” text_background=”off” text_bg_color=”rgba(255,255,255,0.9)” module_bg_color=”rgba(255,255,255,0)” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_padding=”10px|||” parallax=”on” background_color=”rgba(255,255,255,0)” /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built=”1″ fullwidth=”off” specialty=”off” transparent_background=”off” allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” custom_padding=”30px||0px|” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off” background_color=”#1e73be” prev_background_color=”#000000″ next_background_color=”#ffffff” custom_padding_tablet=”0px||0px|” global_module=”1228″][et_pb_row global_parent=”1228″ make_fullwidth=”off” use_custom_width=”off” width_unit=”on” use_custom_gutter=”off” custom_padding=”30px||0px|” allow_player_pause=”off” parallax=”off” parallax_method=”off” make_equal=”off” parallax_1=”off” parallax_method_1=”off” column_padding_mobile=”on” background_position=”top_left” background_repeat=”repeat” background_size=”initial”][et_pb_column type=”4_4″][et_pb_text global_parent=”1228″ background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid” background_position=”top_left” background_repeat=”repeat” background_size=”initial”] [breadcrumb] [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built=”1″ fullwidth=”off” specialty=”off” transparent_background=”off” allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” padding_mobile=”off” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off” gutter_width=”3″ custom_padding_tablet=”0px||0px|” custom_padding_last_edited=”on|desktop” prev_background_color=”#1e73be” next_background_color=”#000000″][et_pb_row][et_pb_column type=”4_4″][et_pb_toggle admin_label=”Index” _builder_version=”3.0.95″ open=”off” title=”Index”]

Section 27 – Impairment of Assets

27.1 Objective and scope. 

27.1.1 Extract from FRS102: Section 27.1 – 27.1A. 

27.1.2 OmniPro comment – Objective and scope. 

27.2 Impairment of inventories. 

27.2.1 Extract from FRS102: Section 27.2 – 27.4

27.2.2 OmniPro comment – Impairment of Inventories. 

27.3 Impairment of assets other than inventories. 

27.3.1 Extract from FRS102: Section 27.5 – 27.6.

27.3.2 OmniPro comment – Impairment of assets other than inventory – assessing if an impairment is required. 

27.4 Impairment – assessing if an impairment is required. 

27.4.1 Extract from FRS102: Section 27.7 – 27.8. 

27.4.2 OmniPro comment 

27.4.2.1 Assessing if an impairment is required. 

27.4.2.2 Cash generating unit 

27.5 Indicators of impairment 

27.5.1 Extract from FRS102: Section 27.9 – 27.10. 

27.5.2 OmniPro comment – Indicators of Impairment 

27.6 Measuring recoverable amount 

27.6.1 Extract from FRS102: Section 27.11 – 27.13. 

27.6.2 OmniPro comment – Measuring recoverable amount 

27.7 Fair value less costs to sell 

27.7.1 Extract from FRS102: Section 27.14 – 27.14A. 

27.7.2 OmniPro comment 

27.7.2.1 Fair value less cost to sell – active market 

27.7.2.2 Fair value less cost to sell – no active market – valuation model 

27.7.2.3 Discount rate for fair value less cost to sell 

27.8 Value in use. 

27.8.1 Extract from FRS102: Section 27.15 – 27.20. 

27.8.2 OmniPro comment 

27.8.2.1 Value in Use rules. 

27.8.2.2 Estimating the future pre-tax cash flows. 

27.8.2.3 Foreign cash flows. 

27.8.2.4 Steps in calculating Value in Use. 

27.8.2.5 Value in use – discount rate. 

27.8.2.6 Value in use – terminal value. 

27.9 Assets held for service potential 

27.9.1 Extract from FRS102: Section 27.20A. 

27.9.2 OmniPro comment – Asset held for service potential 

27.10 Recognising and measuring an impairment loss for a cash-generating unit 

27.10.1 Extract from FRS102: Section 27.21 – 27.23. 

27.10.2 OmniPro comment 

27.10.2.1 Allocation of the improvement loss in a CGU. 

27.10.2.2 Restoration on reduction of assets as a result of impairment 

27.11  Additional requirements for impairment of goodwill 

27.11.2  OmniPro comment 

27.11.2.1 – Impairment of Goodwill 

27.11.2.2 Integrated entity. 

27.12 Reversal of an impairment loss. 

27.12.1 Extract from FRS102: Section 27.28 – 27.30. 

27.12.2 OmniPro comment 

27.12.2.1 Impairment reversals generally. 

27.13 Reversal when recoverable amount was estimated for a cash-generating unit 

27.13.1 Extract from FRS102: Section 27.31. 

27.13.2 OmniPro comment – Reversal of impairment when recoverable amount based on CGU  

27.14 Disclosures. 

27.14.1 Extract from FRS102: Section 27.32 – 27.33A. 

27.14.2 OmniPro comment – Disclosures. 

27.14.2.1 Tangible fixed assets accounting policy disclosure. 

27.14.2.2    Extract from notes to the financial statements. 

27.14.2.2.1 Exceptional item – impairment charge. 

27.14.2.2.2Tangible fixed assets. 

27.14.2.2.3 Extract from profit and loss where impairment is shown as an exceptional item. 

27.14.2.2.4 Extract from notes to the financial statements

27.14.2.2.5 Extract from notes where impairment is not deemed exceptional 

27.14.2.2.6 Financial assets. 

[/et_pb_toggle][/et_pb_column][/et_pb_row][et_pb_row][et_pb_column type=”3_4″][et_pb_text admin_label=”Main Body Text” background_layout=”light” text_orientation=”justified” use_border_color=”off” border_color_all=”off” module_alignment=”left” _builder_version=”3.0.95″]

27.6 Measuring recoverable amount

Even if no impairment is required first an indicator exists that under Section 27.10 of FRS 102, the entity must assess if the residual value, depreciation rate or useful life should change.

27.6.1 Extract from FRS102: Section 27.11 – 27.13

27.11 The recoverable amount of an asset or a cash-generating unit is the higher of its fair value less costs to sell and its value in use. If it is not possible to estimate the recoverable amount of an individual asset, references to an asset in paragraphs 27.12 to 27.20A should be read as references also to an asset’s cash-generating unit.

27.12 It is not always necessary to determine both an asset’s fair value less costs to sell and its value in use. If either of these amounts exceeds the asset’s carrying amount, the asset is not impaired and it is not necessary to estimate the other amount.

27.13 If there is no reason to believe that an asset’s value in use materially exceeds its fair value less costs to sell, the asset’s fair value less costs to sell may be used as its recoverable amount. This will often be the case for an asset that is held for disposal.

27.6.2 OmniPro comment – Measuring recoverable amount

As detailed in the sections 27.11 to 27.13 of FRS 102, where one method shows the recoverable amount is in excess of the carrying amount, then the second method does not have to be completed e.g. if fair value less cost to sell indicates the recoverable amount is greater than carrying amount, then the entity does not have to calculate the value in use.

If the value in use calculation indicates an impairment but the fair value less cost to sell method does not (or vice versa), then no impairment should be booked even where the entity has no intention of selling the asset.


Example 10: Value in use differs from fair value less costs to sell

Company A operates a factory and manufacturers products. The value in use calculation indicates an impairment of the fixed assets. The fair value of the fixed assets alone are well above the carrying amount. The company has no intention of disposing of the asset. In this particular case no impairment should be booked as the fair value is higher than the carrying amount. The intentions of management should be ignored as the company could if it wishes sell these valuable assets at any time.


[/et_pb_text][/et_pb_column][et_pb_column type=”1_4″][et_pb_toggle _builder_version=”3.0.106″ title=”Practical Examples” open=”off”]

Examples:

Example 1: Lowest available CGU. 

Example 2: Lowest available CGU. 

Example 3: A decline in the asset’s market value. 

Example 4: Significant adverse changes that have taken/will take place in the market 

Example 5: Change in assets use. 

Example 6: Introduction of new competitor 

Example 7: Impairment indicators – decision to close. 

Example 8: Performance of an asset is worse than expected. 

Example 9: Investment in subsidiary. 

Example 10: Value in use differs from fair value less costs to sell 

Example 11: Fair value less costs to sell 

Example 12: Determining cash flow to include. 

Example 13: WACC. 

Example 14: Impairment loss for a CGU with goodwill 

Example 15: Restriction of reduction of assets as a result of an impairment 

Example 16: Impairment loss on a CGU with goodwill and non-controlling interests 

Example 17: Reversal of impairment on an individual asset 

Example 18: Reversal of cash generating unit 

Example 19: extract from an accounting policy note and disclosure requirements. 

[/et_pb_toggle][/et_pb_column][/et_pb_row][/et_pb_section]